MS Drug's journey through the body revealed in small study
NCT ID NCT04171310
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study looked at how healthy men absorb, process, and eliminate a new multiple sclerosis drug called SAR442168. Six men took a single dose, and researchers measured how much of the drug left their body in urine and stool. The goal was to understand the drug's metabolism and safety, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 8260001
Nottingham, United Kingdom
Conditions
Explore the condition pages connected to this study.